James E. Wagner Cultivation (TSXV:JWCA) (“JWC” or the “Company”), a licensed producer of cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), is pleased to announce its continued commitment to medical dried cannabis through its participation in Canopy Growth Corporation’s (“Canopy Growth”) curated CraftGrow program (the “Program”). The Program is part of the Spectrum Cannabis online marketplace that brings together high-quality cannabis products. JWC’s product will launch within the already established CraftGrow program on November 1, 2018 and will be available online for purchase at SpectrumCannabis.com.
Participation in the Program is an excellent opportunity for JWC to increase the availability of its dried cannabis products, produced using its proprietary, state-of-the-art aeroponics growth system, GrowthSTORM™.
“JWC is excited to be offering product through the CraftGrow program,” said President and Chief Executive Officer of JWC, Nathan Woodworth. “Canopy Growth Corporation is a world leader in cannabis, and we look forward to our collaboration bringing JWC’s aeroponic cannabis to the patients of Canada!”
Through use of Canopy Growth’s vast platforms, including its extensive distribution infrastructure, JWC’s aeroponically-grown dried cannabis products will be more readily accessible across Canada to medical patients. The first product expected to be offered in the Program is JWC’s high-CBD strain “Cannatonic”. Additionally, JWC anticipates that several of its THC-dominant strains will also become available through the Program.
About James E. Wagner Cultivation Corporation
JWC’s wholly-owned subsidiary is a Licensed Producer under the ACMPR and JWC is a premium cannabis brand, focusing on producing clean, consistent cannabis. JWC uses an advanced and proprietary aeroponic platform named GrowthStormTM. JWC was founded as a family company, based on family values. JWC began as a collective of patients and growers under the Marihuana Medical Access Regulations (the precursor to ACMPR). Since its inception, JWC has remained focused on providing the best possible patient experience. JWC’s operations are based in Kitchener, Ontario. Learn more at www.jwc.ca
About Canopy Growth Corporation
Canopy Growth is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time. Canopy Growth has operations in 12 countries across five continents. Canopy Growth is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public’s understanding of cannabis. Furthermore, through its partly owned subsidiary, Canopy Health Innovations, it has devoted millions of dollars toward cutting edge, commercialized research and IP development. Through partly owned subsidiary Canopy Rivers Corporation, Canopy Growth is providing resources and investment to new market entrants and building a portfolio of stable investments in the sector. From our historic public listing on the Toronto Stock Exchange and New York Stock Exchange to our continued international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth. Canopy Growth has established partnerships with leading sector names including cannabis icon Snoop Dogg, breeding legends DNA Genetics and Green House seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates ten licensed cannabis production sites with over 4.3 million square feet of production capacity, including over 500,000 square feet of GMP certified production space. For more information visit www.canopygrowth.com
Notice regarding forward-looking statements:
This press release contains statements including forward-looking information for purposes of applicable securities laws (“forward-looking statements”) about JWC and its business and operations which include, among other things, its participation in Canopy Growth’s CraftGrow Program and details regarding the products that will be offered through the Program. The forward-looking statements can be identified by the use of such words as “anticipated”, “will”, “expected”, “approximately”, “may”, “could”, “would” or similar words and phrases. Forward- looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results to differ materially from those implied in the forward-looking statements. For example, risks include risks regarding the cannabis industry, economic factors, the equity markets generally, funding and grant related risks and risks associated with growth and competition as well as the risks identified in the Company’s Filing Statement available under the Company’s profile at www.sedar.com. Although JWC has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release and are based on current assumptions which management believes to be reasonable. The Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For more information about this release, please contact
Nathan Woodworth, President & CEO of JWC
Phone: (519) 594-0144 x421
George Aizpurua, Vice President of First Canadian Capital Corp.
Phone: (416) 742-5600